# | Title | Journal | Year | Citations |
---|
1 | Discovery of curcumin, a component of golden spice, and its miraculous biological activities | Clinical and Experimental Pharmacology and Physiology | 2012 | 637 |
2 | MULTIPLE COMPARISON PROCEDURES UPDATED | Clinical and Experimental Pharmacology and Physiology | 1998 | 523 |
3 | AGE‐RELATED CHANGES IN THE STRUCTURE AND FUNCTION OF SKELETAL MUSCLES | Clinical and Experimental Pharmacology and Physiology | 2007 | 523 |
4 | ARGINASE: A CRITICAL REGULATOR OF NITRIC OXIDE SYNTHESIS AND VASCULAR FUNCTION | Clinical and Experimental Pharmacology and Physiology | 2007 | 457 |
5 | A SIMPLE METHOD FOR ESTIMATING 24 H URINARY SODIUM AND POTASSIUM EXCRETION FROM SECOND MORNING VOIDING URINE SPECIMEN IN ADULTS | Clinical and Experimental Pharmacology and Physiology | 1993 | 426 |
6 | HIGH INCIDENCE OF PRIMARY ALDOSTERONISM IN 199 PATIENTS REFERRED WITH HYPERTENSION | Clinical and Experimental Pharmacology and Physiology | 1994 | 423 |
7 | Statistical Techniques For Comparing Measurers And Methods Of Measurement: A Critical Review | Clinical and Experimental Pharmacology and Physiology | 2002 | 385 |
8 | Curcumin‐loaded poly(ε‐caprolactone) nanofibres: Diabetic wound dressing with anti‐oxidant and anti‐inflammatory properties | Clinical and Experimental Pharmacology and Physiology | 2009 | 364 |
9 | NITRERGIC TRANSMISSION: NITRIC OXIDE AS A MEDIATOR OF NON-ADRENERGIC, NON-CHOLINERGIC NEURO-EFFECTOR TRANSMISSION | Clinical and Experimental Pharmacology and Physiology | 1992 | 359 |
10 | THE 'ABC' OF GABA RECEPTORS: A BRIEF REVIEW | Clinical and Experimental Pharmacology and Physiology | 1999 | 347 |
11 | ANTISENSE OLIGONUCLEOTIDES: FROM DESIGN TO THERAPEUTIC APPLICATION | Clinical and Experimental Pharmacology and Physiology | 2006 | 332 |
12 | ENDOTHELIAL CELL RESPONSES TO HYPOXIC STRESS | Clinical and Experimental Pharmacology and Physiology | 1999 | 309 |
13 | Molecular mechanisms for tumour resistance to chemotherapy | Clinical and Experimental Pharmacology and Physiology | 2016 | 304 |
14 | DIFFERENCES BETWEEN PATHOLOGICAL AND PHYSIOLOGICAL CARDIAC HYPERTROPHY: NOVEL THERAPEUTIC STRATEGIES TO TREAT HEART FAILURE | Clinical and Experimental Pharmacology and Physiology | 2007 | 298 |
15 | Chemistry And Biological Effects Of Dietary Phenolic Compounds: Relevance To Cardiovascular Disease | Clinical and Experimental Pharmacology and Physiology | 2000 | 294 |
16 | Antiviral activities of extracts and selected pure constituents of Ocimum basilicum | Clinical and Experimental Pharmacology and Physiology | 2005 | 286 |
17 | Central Mechanisms Underlying Short- And Long-Term Regulation Of The Cardiovascular System | Clinical and Experimental Pharmacology and Physiology | 2002 | 272 |
18 | CURCUMIN, THE ACTIVE PRINCIPLE OF TURMERIC (CURCUMA LONGA), AMELIORATES DIABETIC NEPHROPATHY IN RATS | Clinical and Experimental Pharmacology and Physiology | 2006 | 271 |
19 | THE CHOLINERGIC ‘PITFALL’: ACETYLCHOLINE, A UNIVERSAL CELL MOLECULE IN BIOLOGICAL SYSTEMS, INCLUDING HUMANS | Clinical and Experimental Pharmacology and Physiology | 1999 | 267 |
20 | SPECIAL ARTICLE COMPARING METHODS OF MEASUREMENT | Clinical and Experimental Pharmacology and Physiology | 1997 | 266 |
21 | Confidence in Altman–Bland plots: A critical review of the method of differences | Clinical and Experimental Pharmacology and Physiology | 2010 | 263 |
22 | Circumventricular Organs: Definition And Role In The Regulation Of Endocrine And Autonomic Function | Clinical and Experimental Pharmacology and Physiology | 2000 | 256 |
23 | Neuroexcitatory Effects Of Morphine And Hydromorphone: Evidence Implicating The 3-Glucuronide Metabolites | Clinical and Experimental Pharmacology and Physiology | 2000 | 255 |
24 | COPPER AND ANGIOGENESIS: UNRAVELLING A RELATIONSHIP KEY TO CANCER PROGRESSION | Clinical and Experimental Pharmacology and Physiology | 2009 | 251 |
25 | MAXIMAL LACTATE STEADY STATE IN RUNNING MICE: EFFECT OF EXERCISE TRAINING | Clinical and Experimental Pharmacology and Physiology | 2007 | 249 |
26 | ARSENIC-INDUCED OXIDATIVE STRESS AND ITS REVERSIBILITY FOLLOWING COMBINED ADMINISTRATION OF N-ACETYLCYSTEINE AND MESO 2,3-DIMERCAPTOSUCCINIC ACID IN RATS | Clinical and Experimental Pharmacology and Physiology | 1999 | 245 |
27 | Diversity Within Pericytes | Clinical and Experimental Pharmacology and Physiology | 2000 | 244 |
28 | EVIDENCE FOR A SUPRASPINAL CONTRIBUTION TO HUMAN MUSCLE FATIGUE | Clinical and Experimental Pharmacology and Physiology | 2006 | 238 |
29 | MUSCLE DAMAGE IN MDX (DYSTROPHIC) MICE: ROLE OF CALCIUM AND REACTIVE OXYGEN SPECIES | Clinical and Experimental Pharmacology and Physiology | 2006 | 238 |
30 | Transcriptional Activation Of Energy Metabolic Switches In The Developing And Hypertrophied Heart | Clinical and Experimental Pharmacology and Physiology | 2002 | 236 |
31 | SHEEP MODELS OF INTRAUTERINE GROWTH RESTRICTION: FETAL ADAPTATIONS AND CONSEQUENCES | Clinical and Experimental Pharmacology and Physiology | 2008 | 233 |
32 | MicroRNA‐320 EXPRESSION IN MYOCARDIAL MICROVASCULAR ENDOTHELIAL CELLS AND ITS RELATIONSHIP WITH INSULIN‐LIKE GROWTH FACTOR‐1 IN TYPE 2 DIABETIC RATS | Clinical and Experimental Pharmacology and Physiology | 2009 | 233 |
33 | Adaptations Of Skeletal Muscle To Prolonged, Intense Endurance Training | Clinical and Experimental Pharmacology and Physiology | 2002 | 232 |
34 | Functional Roles Of KATP Channels In Vascular Smooth Muscle | Clinical and Experimental Pharmacology and Physiology | 2002 | 232 |
35 | FLUID MECHANICS OF ARTIFICIAL HEART VALVES | Clinical and Experimental Pharmacology and Physiology | 2009 | 228 |
36 | FETAL LUNG LIQUID: A MAJOR DETERMINANT OF THE GROWTH AND FUNCTIONAL DEVELOPMENT OF THE FETAL LUNG | Clinical and Experimental Pharmacology and Physiology | 1995 | 226 |
37 | Fibroblast Growth Factors In The Developing Central Nervous System | Clinical and Experimental Pharmacology and Physiology | 2001 | 222 |
38 | STRUCTURE AND FUNCTION OF URIDINE DIPHOSPHATE GLUCURONOSYLTRANSFERASES | Clinical and Experimental Pharmacology and Physiology | 1997 | 216 |
39 | Determinants of kidney oxygen consumption and their relationship to tissue oxygen tension in diabetes and hypertension | Clinical and Experimental Pharmacology and Physiology | 2013 | 216 |
40 | Biopharmaceutical Considerations In Topical Ocular Drug Delivery | Clinical and Experimental Pharmacology and Physiology | 2000 | 211 |
41 | SEX STEROID CONTROL OF MOOD, MENTAL STATE AND MEMORY | Clinical and Experimental Pharmacology and Physiology | 1998 | 209 |
42 | Haemodynamic influences on kidney oxygenation: Clinical implications of integrative physiology | Clinical and Experimental Pharmacology and Physiology | 2013 | 209 |
43 | OPIOID RECEPTOR SIGNALLING MECHANISMS | Clinical and Experimental Pharmacology and Physiology | 1999 | 207 |
44 | GAPDH: A common enzyme with uncommon functions | Clinical and Experimental Pharmacology and Physiology | 2012 | 207 |
45 | ANTIVIRAL EFFECTS OF SAIKOSAPONINS ON HUMAN CORONAVIRUS 229E IN VITRO | Clinical and Experimental Pharmacology and Physiology | 2006 | 206 |
46 | 'Steady-state' properties of the baroreceptor-heart rate reflex in essential hypertension in man | Clinical and Experimental Pharmacology and Physiology | 1974 | 203 |
47 | Andrographolide and its analogues: versatile bioactive molecules for combating inflammation and cancer | Clinical and Experimental Pharmacology and Physiology | 2012 | 203 |
48 | OXIDIZED LOW-DENSITY LIPOPROTEIN INDUCES ENDOTHELIAL PROGENITOR CELL SENESCENCE, LEADING TO CELLULAR DYSFUNCTION | Clinical and Experimental Pharmacology and Physiology | 2004 | 201 |
49 | BENEFICIAL EFFECTS OF ALOE VERA LEAF GEL EXTRACT ON LIPID PROFILE STATUS IN RATS WITH STREPTOZOTOCIN DIABETES | Clinical and Experimental Pharmacology and Physiology | 2006 | 200 |
50 | AGE, HYPERTENSION AND ARTERIAL FUNCTION | Clinical and Experimental Pharmacology and Physiology | 2007 | 199 |